Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
First Claim
1. A method for the treatment of microbial infections of ears and sinuses in a human, comprising administering to said human a pharmaceutical preparation comprising lactoferrins, lysozyme and defensins in an amount effective for a reduction of said microbial infection, wherein said microbial infection comprises a bacteria selected from the group consisting of Streptococcus pneumoniae, non-typeable Haemophilus influenzae (NTHi), and Moraxella catarrhalis, said pharmaceutical preparation further comprising a pharmaceutically acceptable carrier, wherein said carrier has a concentration of sodium chloride salt below about 100 mM.
3 Assignments
0 Petitions
Accused Products
Abstract
Disclosed herein is a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin and defensins, were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
190 Citations
16 Claims
- 1. A method for the treatment of microbial infections of ears and sinuses in a human, comprising administering to said human a pharmaceutical preparation comprising lactoferrins, lysozyme and defensins in an amount effective for a reduction of said microbial infection, wherein said microbial infection comprises a bacteria selected from the group consisting of Streptococcus pneumoniae, non-typeable Haemophilus influenzae (NTHi), and Moraxella catarrhalis, said pharmaceutical preparation further comprising a pharmaceutically acceptable carrier, wherein said carrier has a concentration of sodium chloride salt below about 100 mM.
Specification